GTC's 2011 8th Anti-infectives Partnering and Deal-Making Conference, taking place on November 7-8, 2011 in Boston, MA, will contribute to the on-going battle against the ever-changing infectious threats by having experts with direct experiences in the field discuss a wide variety of topics on infectious diseases.

BIO-Europe is Europe's largest partnering conference, serving the global biotechnology industry. The conference annually attracts leading dealmakers from biotech, pharma and finance along with the most exciting emerging companies.

BIO-Europe 2011 Highlights

14,765 scheduled one-to-one meetings

3,565 licensing opportunities posted

2,825 attendees

1,596 companies

183 company presentations

94 international exhibitors

48 countries

20 workshops and panel sessions

Caixa Capital Risc, the private equity branch of "la Caixa", led this round, and was joined by existing partners and the management team. The company also obtained support from the Spanish National Innovation Company (ENISA). The new capital injection is aimed at accelerating the growth of the company.

The BIO International Convention is the largest global event for the biotechnology industry and attracts the biggest names in biotech, offers key networking and partnering opportunities, and provides insights and inspiration on the major trends affecting the industry.

The capacity of your company to effectively do business across borders depends on your team's capabilities.

Health problems caused by infectious diseases, cardiovascular disease, and cancer impact the well-being of people across the world. It follows that biotech solutions developed here in Catalonia are not limited by geography in their application.

Omnia Molecular has attended as exhibitor the most important biotechnological event at the pharma industry.

Omnia Molecular has attended as exhibitor the most important biotechnological event at the pharma industry.

In the Entrepreneurial sings framework of May the 28th, the Barcelona Entrepreneurial City Awards ceremony took place. Omnia was finalist for the "best new innovative company".